Differences in anticoagulation strategy and outcome in atrial fibrillation patients with chronic kidney disease: a CODE-AF registry study

Differences in anticoagulation strategy and outcome in atrial fibrillation patients with chronic kidney disease: a CODE-AF registry study

Abstract Purpose Dose reduction of non-vitamin K antagonist oral anticoagulants (NOACs) is indicated in patients with atrial fibrillation (AF) with renal impairment. This study investigated anticoagulation patterns and outcomes in patients with chronic kidney disease (CKD). Materials and methods In...

Full description

Bibliographic Details
Main Authors: Yeon-Jik Choi, Jae-Sun Uhm, Tae-Hoon Kim, Myung-Jin Cha, Jung Myung Lee, Junbeom Park, Jin-Kyu Park, Ki-Woon Kang, Jaemin Shim, Jun Kim, Hyung Wook Park, Eue-Keun Choi, Jin-Bae Kim, Changsoo Kim, Young Soo Lee, Boyoung Joung
Format: Article
Language:English
Published: BMC 2020-02-01
Series:International Journal of Arrhythmia
Subjects:
Atrial fibrillation
Anticoagulation
Kidney diseases
Stroke
Online Access:https://doi.org/10.1186/s42444-020-0011-2

Internet

https://doi.org/10.1186/s42444-020-0011-2

Similar Items